Vitamins
Minerals
Fitness Nutrition
Omega & Fish Oil
Nutritional Drinks
Digestive Care
Diabetic Care
Bone & Joints Care
Respiratory Care
Women Care
Skin Care
Ear Nose Throat
Sexual Wellness
Liver Care
Immunity Boosters
Skin Care
Oral Care
Hair Care
Men Grooming
Baby Food
Baby Hair Care
Baby Skin Care
Baby Bath Care
Diapers
Feminine Hygiene
Women Grooming
Women Nutrition
Blood Glucose
Blood Pressure
Support & Braces
Health Vitals
Test Kits
Nebulizers
Oral Contraceptives
Condoms
Pleasure Enhancers
Protective Gear
Personal & Home
Is a sodium-glucose cotransporter 2 (sglt2) inhibitor.
Is a biguanide medication that helps control blood sugar levels.
Type 2 diabetes mellitus (T2DM) in adults to improve glycemic control, particularly when diet and exercise alone are not sufficient.
May be used alone or in combination with other diabetes medications.
Remogliflozin etabonate works by blocking the reabsorption of glucose in the kidneys, leading to increased urinary glucose excretion and lower blood sugar levels. Metformin reduces glucose production by the liver and improves insulin sensitivity in the body.
Store at room temperature, protected from moisture and light. Keep out of reach of children.
The dosage of Remogliflozin etabonate + Metformin is individualized and determined by your doctor based on your medical condition and response to treatment.
Typically taken once daily, with or without food.
Follow your doctor's instructions carefully regarding the dosage, frequency, and timing of your medication.
Serious side effects are less common but may include: lactic acidosis (build-up of lactic acid in the blood), kidney problems, liver problems, heart failure.
Common side effects may include: headache, nausea, vomiting, diarrhea, low blood sugar (hypoglycemia), urinary tract infections.
May increase the risk of lactic acidosis. Consult your doctor about alcohol consumption while taking this medication.
May cause dizziness or low blood sugar, which could impair driving or operating machinery. Exercise caution.
Not recommended during pregnancy or breastfeeding. Discuss with your doctor about alternative options.
Not recommended for children. Safety and efficacy in children have not been established.
May be harmful to people with kidney disease. Your doctor will monitor your kidney function.
May be harmful to people with liver disease. Your doctor will monitor your liver function.
Please consult your doctor or pharmacist for more detailed information on Remogliflozin etabonate + Metformin.
Refer to the official product information leaflet provided by the manufacturer.
